Associations of MYC protein expression and gene status with breast cancer subtypes and outcome in patients treated with anthracycline-based adjuvant chemotherapy

被引：0
|
作者：
Batistatou, A.
Razis, E.
Bobos, M.
Tsolaki, E.
Timotheadou, E.
Alexopoulou, Z.
Goussia, A.
Gogas, H.
Koutras, A.
Karina, M.
Pentheroudakis, G.
Efstratiou, I.
Petraki, K.
Sotiropoulou, M.
Pavlakis, K.
Koletsa, T.
Kotoula, V.
Fountzilas, G.
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Athens, Greece
[2] Hlth Data Specialists Ltd, Athens, Greece
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-50
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-50
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cisplatin and paclitaxel for treatment of patients with advanced or metastatic breast cancer, previously treated with anthracycline-based chemotherapy
    Munarriz, A
    Oltra, A
    Santaballa, A
    Segura, A
    Pastor, M
    Montalar, J
    Herranz, C
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 765 - 768
  • [42] Late-onset cardiotoxicity in Anthracycline-based chemotherapy for breast cancer patients
    Mata Caballero, R.
    Serrano Antolin, J. M.
    Gonzalez Garcia, I. A.
    Muniz Garcia, J.
    Curcio Ruigomez, A.
    Gutierrez Landaluce, C.
    Morales Garcia, L. J.
    Del Castillo Arrojo, S.
    Guerra Martinez, J. A.
    Graupner Abad, C.
    Jimenez Hernandez, R. M.
    Cristobal Varela, C.
    Malon Gimenez, D.
    Talavera Calle, P.
    Alonso Martin, J. J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 118 - 119
  • [43] Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine
    Ari, Ferda
    Napieralski, Rudolf
    Ulukaya, Engin
    Dere, Egemen
    Colling, Christoph
    Honert, Katja
    Krueger, Achim
    Kiechle, Marion
    Schmitt, Manfred
    CELL BIOCHEMISTRY AND FUNCTION, 2011, 29 (08) : 651 - 659
  • [44] Cardiac Tolerability of Concurrent Administration of Trastuzumab and Anthracycline-Based Regimen as Adjuvant Chemotherapy for Breast Cancer
    Watanabe, Naoki
    Otsuka, Shoko
    Sasaki, Yoko
    Shimojima, Reiko
    Wani, Yoji
    Uchino, Kaori
    BREAST CARE, 2014, 9 (01) : 46 - 51
  • [45] PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy
    Liu, M. C.
    Pitcher, B. N.
    Mardis, E. R.
    Davies, S. R.
    Snider, J. E.
    Vickery, T.
    Reed, J. P.
    DeSchryver, K.
    Singh, B.
    Friedman, P. N.
    Gradishar, W. J.
    Perez, E. A.
    Martino, S.
    Citron, M. L.
    Norton, L.
    Winer, E. P.
    Hudis, C. A.
    Perou, C. M.
    Ellis, M. J.
    Barry, W. T.
    CANCER RESEARCH, 2012, 72
  • [46] Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Marcella Mottolese
    Maria Benevolo
    Girolamo Del Monte
    Simonetta Buglioni
    Paola Papaldo
    Cecilia Nisticò
    Franco Di Filippo
    Stefania Vasselli
    Patrizia Vici
    Claudio Botti
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 722 - 729
  • [47] HMGA2 expression and response to anthracycline-based preoperative chemotherapy in patients with operable breast cancer
    Puglisi, F.
    Ermacora, P.
    Driol, P.
    Masolini, P.
    Alessi, B.
    Pisa, F. E.
    Pandolfi, M.
    Mansutti, M.
    Giancotti, V.
    Di Loreto, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Mottolese, M
    Benevolo, M
    Del Monte, G
    Buglioni, S
    Papaldo, P
    Nisticò, C
    Di Filippo, F
    Vasselli, S
    Vici, P
    Botti, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (12) : 722 - 729
  • [49] Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer
    Mills, Paul J.
    Ancoli-Israel, Sonia
    Parker, Barbara
    Natarajan, Loki
    Hong, Suzi
    Jain, Shamini
    Sadler, Georgia R.
    von Kaenel, Roland
    BRAIN BEHAVIOR AND IMMUNITY, 2008, 22 (01) : 98 - 104
  • [50] Predictive factors for anthracycline-based chemotherapy for human breast cancer
    Miyoshi, Yasuo
    Kurosumi, Masafumi
    Kurebayashi, Junichi
    Matsuura, Nariaki
    Takahashi, Masato
    Tokunaga, Eriko
    Egawa, Chiyomi
    Masuda, Norikazu
    Kono, Seishi
    Morimoto, Koji
    Kim, Seung Jin
    Okishiro, Masatsugu
    Yanagisawa, Tetsu
    Ueda, Satsuki
    Taguchi, Tetsuya
    Tamaki, Yasuhiro
    Noguchi, Shinzaburo
    BREAST CANCER, 2010, 17 (02) : 103 - 109
12345